Medicines and Related Substances Act, 1965
R 385
3. Key measurement principles |
3.4 Modified Flow-Through Principle
3.5 Exclusion of Specified Entities when Determining Ownership
3.8 Recognition of Ownership After the Sale or Loss of Shares by Black Participants
3.9 Broad-based Ownership Schemes and Employee Share Ownership Programme
3.11 Section 21 Companies and Companies Limited by Guarantee
3.13 Options and Share Warrants
3.14 Equity Instruments Carrying Preference Rights
